Access to Trial Meds Needs Market Incentive, Conservatives Say

Access to Trial Meds Needs Market Incentive, Conservatives Say By Jeannie Baumann and Alex Ruoff | July 16, 2019 05:41AM ET | Bloomberg Law Lawmakers and conservative advocates who fought to make it easier for Americans to use experimental medicines are floating a new twist: permitting drugmakers to sell unapproved drugs at a profit. The … Continue reading Access to Trial Meds Needs Market Incentive, Conservatives Say